Reported results
- Consolidated net revenue (GAAP) was $81.4M in Q2 FY2027, an increase of 22% compared to Q2 FY2026.
- Consolidated gross margin (GAAP) was 29% in Q2 FY2027, compared to 33% in Q2 FY2026.
- Non-GAAP adjusted gross margin was 31% in Q2 FY2027, compared to 33% in Q2 FY2026.
- GAAP net loss in Q2 FY2027 was $40,694 thousand, compared to a net loss of $4,978 thousand in Q2 FY2026.
- Non-GAAP adjusted EBITDA loss for Q2 FY2027 was $2.9M, an improvement of $0.2M or 6% compared to Q2 FY2026.
- Non-GAAP free cash outflow decreased from $19.2M in Q2 FY2026 to $15.5M in Q2 FY2027.
Notes
The release notes continued costs related to the restatement of consolidated financial statements in connection with the review of financial reporting matters related to the BioSteel business unit for prior periods.
Price and volatility reaction
Source
The figures above come from the earnings release the company filed with the SEC on 2026-11-06 (8-K, Item 2.02). Read the original filing on sec.gov.
